"Isoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
| Descriptor ID |
D007518
|
| MeSH Number(s) |
D12.776.124.486.485.114.664 D12.776.124.790.651.114.664 D12.776.377.715.548.114.664
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Isoantibodies".
This graph shows the total number of publications written about "Isoantibodies" by people in this website by year, and whether "Isoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2005 | 1 | 2 | 3 |
| 2006 | 3 | 2 | 5 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 3 | 5 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 2 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantibodies" by people in Profiles.
-
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 Dec; 30(12):1139-1154.
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 02; 38(2):e15249.
-
Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients. Clin Transplant. 2023 01; 37(1):e14853.
-
Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions. Hum Immunol. 2022 May; 83(5):467-475.
-
HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2021 10; 96(10):2727-2728.
-
Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplant Proc. 2021 Jul-Aug; 53(6):1865-1871.
-
Practice patterns and clinical outcomes of platelet alloimmunization in a comprehensive cancer center. Transfus Apher Sci. 2021 Jun; 60(3):103096.
-
The shared epitope phenomenon-A potential impediment to virtual crossmatch accuracy. Clin Transplant. 2020 08; 34(8):e13906.
-
Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series. Am J Kidney Dis. 2020 09; 76(3):374-383.
-
Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital. BMC Pregnancy Childbirth. 2019 Oct 15; 19(1):356.